Metuchen, NJ, United States of America

Alpa Patel

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Becton Dickinson and Company Limited. Active years: 2017-2018.


% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Alpa Patel: Innovator in Medical Device Technology

Introduction

Alpa Patel is a notable inventor based in Metuchen, NJ (US), recognized for her contributions to medical device technology. With a total of 2 patents, she has made significant strides in the field of drug transfer systems.

Latest Patents

One of her latest patents is an infusion adapter for drug transfer assembly. This innovative device is designed for connection with an infusion fluid container. It includes a connection portion with an anchor component that connects to an injection port of the infusion fluid container. The first port is adapted for connection with a syringe assembly containing medication fluid. This design ensures that the infusion adapter securely connects to the infusion fluid container, preventing disconnection once attached.

Career Highlights

Alpa Patel is currently employed at Becton Dickinson and Company Limited, where she continues to develop and refine medical technologies. Her work focuses on enhancing the safety and efficiency of drug delivery systems.

Collaborations

Throughout her career, Alpa has collaborated with talented individuals such as Gert Hanner and Fredrik Stoltz, contributing to the advancement of innovative medical solutions.

Conclusion

Alpa Patel's work in the field of medical devices exemplifies her commitment to improving healthcare through innovation. Her patents reflect her dedication to creating safer and more effective drug transfer systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…